LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) announced today the launch of the new Arrow ® FlexBlock ™ Continuous Peripheral Nerve Block Catheter. The FlexBlock Catheter was ...
Teleflex TFX recently signed the Peripheral Access purchasing agreement with the leading healthcare improvement company, Premier, Inc. PINC. Effective from Dec 1, 2023, the new agreement allows ...
Please provide your email address to receive an email when new articles are posted on . The FDA has designated a recall of a peripheral catheter system as class I, the most serious kind. Teleflex and ...
WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement ...
Teleflex Receives FDA 510(k) Clearance for ARROW® FlexBlock™ Continuous Peripheral Nerve Block Cathe
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) today announced the ARROW FlexBlock continuous peripheral nerve block catheter has received 510(k) clearance from the U.S. Food and ...
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will ...
PTA balloon catheters combine angioplasty with targeted injection system in a single device for use in below the knee procedures. WAYNE, Pa. -- Teleflex Incorporated, a leading global provider of ...
December 30, 2010 — Arrow International is voluntarily recalling certain intra-aortic balloon (IAB) catheters because they can become stuck in their sheaths, possibly delaying therapy or leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback